Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
By 2024, the cannabis market in California is projected to reach $7.2 BILLION – boosted significantly by California’s recreational cannabis market- a 19% compound annual growth rate (CAGR) over the next five years. (Source)
California is the world's biggest cannabis market...
GPFT is a California-based business, which is where Hourglassâ„¢ will launch this year on a select retail basis...
Initially, GPFT will be focused on "owning their backyard," launching in a smart, controlled manner... in a way that requires smart metered investment... AND... There's no better place than California to build a sales and investment story around a product like Hourglassâ„¢...
Of course, we investors all expect Hourglassâ„¢ to become a "national" product in time - to be sold in every U.S. state with a legal market, but overnight expansion is not possible for any early-stage venture because of the capital required and the time it will take to obtain distribution and regulatory approval...
Thus, my focus has been on the rapidly growing California market when calculating possible revenue projections scenarios for Hourglassâ„¢...
Check out the Chart (below)! In terms of marijuana consumption methods, edibles are not harmful to the lungs and individual servings of these types of products typically are not shared between users, making them a more attractive option amid the COVID-19 pandemic. For a while, we have been slowly witnessing consumer behavior shift towards healthier methods of consumption, but the pandemic has really catalyzed a rapid shift. Health is now on everyone's minds.
- The market share for edibles is increasing significantly...
- The market share for the flower, concentrates, preroll is dropping...
- The Market share for vape pens grew slightly due to the innovation in that space - the emergence of more natural brands, and new vape pen dosing methods (see brands such as https://dosist.com/)
*** The market share for topicals dropped... however topicals currently do not get you high and produce local effects only.... they are seen as a luxury product and are not of great utility to the mainstream cannabis consumer due to inability to produce full benefits. THIS IS ABOUT TO CHANGE WITH HOURGLASSâ„¢
My main point is that we are seeing a rapidly growing California cannabis market and consumer behaviors shift rapidly toward healthier methods of consumption. I have plenty of data to back this up. Smoking is out, edibles are in. The market is shifting towards healthy consumption methods. Since edibles are not without problems of their own (unhealthy ingredients such as corn syrup and dyes, and unpredictable effects due to first-pass metabolism through the liver), companies such as GPFT are seizing the opportunity to potentially disrupt the industry with innovative new, HEALTHIER delivery methods... HOURGLASSâ„¢
Indeed it takes time to educate consumers about a new product. Indeed it takes time to grow and scale a product... HOWEVER... Market trends are in our favor, and consumers are demanding healthier, new products like Hourglassâ„¢. Hourglassâ„¢ is at an intersection of several rapidly growing trends. Do you really think the cannabis user of the future will be eating cannabis cookies and vaping? Just apply the cream!
(WATCH THE VIDEO if you don't yet know about Hourglassâ„¢...)
In 4 years, I believe that Hourglassâ„¢ could conservatively represent a $30M -$40M annual revenue opportunity in just the State of California alone. What do you think?
Agreed! Looking forward to GPFT revenue news/10Q this week.
The potential here is HUGE.
Unlike so many other OTC companies, GPFT is not a pre-revenue business. Their existing cannabis business is growing. Earnings are next week and should demonstrate solid growth...
Grapefruit's Hourglassâ„¢ topical delivery cream is a truly disruptive, breakthrough technology, one that fundamentally changes the way individuals will use cannabinoids to obtain their unique benefits... the future of the cannabis industry lies in dosing and delivery.
Considering the expansion of their existing business + the disruptive potential of Grapefruit's Hourglassâ„¢ topical delivery cream, GPFT should realistically be trading at 4-5x today's price.
Then... at some point, PPS will be based on sales, velocity, and projections, which will be developed by analysts as the story further unfolds.
GPFT Today's strong close (up 35%) is only the beginning of what is to come... Hourglassâ„¢ will disrupt the industry.
2 VERY IMPORTANT PRESS RELEASES
07/28/2020. Zylo and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market
07/27/2020. Grapefruit USA, Inc. Announces Formal Execution of its License Agreement with Zylö Therapeutics Inc. Granting Grapefruit an Exclusive License for use of Zylö’s Patented Z-Podâ„¢ Delivery System which drives Grapefruit’s Disruptive Hourglassâ„¢ Time Release THC+Cannabinoid Topical Cream
Utilizing the world’s first (and only) patented time-release nanoparticle delivery system for cannabis, Grapefruit’s Hourglass™ is the ONLY cannabis transdermal that can penetrate five layers of skin, and break the blood-brain barrier, to deliver beneficial cannabinoids into the bloodstream in a predictable, steady dose over time.
Grapefruit’s innovation allows cannabis consumers to obtain the desired medical benefits from the plant without smoking and sacrificing their health in exchange... This is a game-changer for the industry!!!
WATCH THE VIDEO:
GPFT Today's strong close (up 35%) is only the beginning of what is to come... Hourglassâ„¢ will disrupt the industry.
2 VERY IMPORTANT PRESS RELEASES
07/28/2020. Zylo and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market
07/27/2020. Grapefruit USA, Inc. Announces Formal Execution of its License Agreement with Zylö Therapeutics Inc. Granting Grapefruit an Exclusive License for use of Zylö’s Patented Z-Podâ„¢ Delivery System which drives Grapefruit’s Disruptive Hourglassâ„¢ Time Release THC+Cannabinoid Topical Cream
Utilizing the world’s first (and only) patented time-release nanoparticle delivery system for cannabis, Grapefruit’s Hourglass™ is the ONLY cannabis transdermal that can penetrate five layers of skin, and break the blood-brain barrier, to deliver beneficial cannabinoids into the bloodstream in a predictable, steady dose over time.
Grapefruit’s innovation allows cannabis consumers to obtain the desired medical benefits from the plant without smoking and sacrificing their health in exchange... This is a game-changer for the industry!!!
WATCH THE VIDEO:
GPFT OTCQB UPLIST.
Here's your LAST chance to get shares below $0.03!
ONWARD!
GPFT filed their OTCQB certification yesterday (07/09/2020). We may see them listed back on the QB tier as early as today...
FORWARD PROGRESS...
GPFT OTCQB CERTIFICATION FILING JULY 9, 2020
Please review the share structure.
Public float is: 74,647,684
See image from filing below:
Good morning!
If anyone here picked up GPFT shares over the last 2 weeks, get ready to be in the money... and I'm not saying this because of the post about an IR agency being on board.
Investor relations (IR) is a key activity, and I'm glad to see that GPFT is beginning to build out a plan to put their information in front of more investors.
What I'm excited about is that all signs point to a reversal. No large bid hits yesterday... The seller is out. It's only up from here.
I've also spoken to management in the past, and they are very familiar with The Sarbanes-Oxley Act, and the reporting requirements for publicly traded companies. They are dedicated to the accurate dissemination of information. Brilliant leadership here, and I believe they've properly vetted affordable IR agencies at this stage.
It will be BEAUTIFUL.
Recent market volatility notwithstanding, cannabis will create tremendous disruption across many old-line businesses in health care, biotechnology, pharmaceuticals, alcohol, tobacco, health and wellness, and nutraceuticals to name a few. In the present, intermediate-term and for the next 10 years, responsible and thoughtful exposure to the cannabis industry is an essential part of a well-balanced portfolio.
The disruptive Hourglass "Patchless Patch" topical product with nanoparticles is why I'm here.
The future of cannabis lies in dosing and delivery... GPFT has that figured out.... and that's why I'm a buyer.
This isn't just an incremental improvement in cannabis... we're talking disruptive potential.
I believe an investment at these levels (2-3 cents) today will be yield an ROI of 5x by the end of August 2020, and 10x by the end of the year, December 2020... assuming that the company starts offering guidance on this product, and gets it successfully commercialized and fully generating revenue by the end of Q4... the speculation will drive up the valuation.
The TAM for a product like Hourglass is huge.
VIDEO: Hourglassâ„¢ Patchless Patchâ„¢ (THC + CBD) PATENTED Time Release Topical | Grapefruit USA (OTC: GPFT)
Great post and great information. Can one of the admins pin this for quick reference?
Thanks sun_funner for sharing FACT!!!
Also, if you invest in OTC companies... Going concerns are extremely common and part of the risk disclosure part of public reporting.
Almost every public company has a going concern right now due to COVID 19... and the smart companies disclose this risk.
It's legal protection... healthy disclosure... and nothing more.
I was buying at $0.03, and trying to push it up then realized that it was a rushed, somewhat messy strategy. No use paying a premium for shares on the ASK if 5 minutes after I buy on the ask, the bid gets hit. My strategy was to shake some loose down here... I've vacuumed some up at $0.023, $0.024, and 0.025...
Wow... it's tough to see it down here, but I realize this is very temporary.
The stock is now starting to behave a lot differently. It seems the seller is almost out of shares.
Time to start ticking up again.
Let's vacuum up some shares!
My $03 bid was hit!
I'm a buyer here... GPFT... and I'm not going to let it go below $0.03. :)
Time to turn this one around. No more funny business.
I'm alive and well. I got very busy as an angel investor and business owner, and didn't have a lot of time to post. I recently had an exit and have more time. Now I'm back, and I'll talk about companies that I'm investing in on a very limited basis. I hope to see you around the boards...
I have a long-term investment strategy that involves finding diamonds in the rough, performing painstaking due diligence, and buying and holding. Remember this one? https://investorshub.advfn.com/boards/read_msg.aspx?message_id=56471867 -- I made 7 figures there... and that opened my world to angel investing. I invest in products and teams with potential. GPFT has gas in the tank.... adding to my position now. It's wonderful that GPFT is public and we can buy shares in the market easily.
GPFT - huge upside potential here. $$$
I have been loading at these levels. $0.03 will not last long.
Grapefruit is NOT pre-revenue. They are generating revenues and there is a growth story here on their existing product lines... I expect a stellar 2nd Q revenue report based on the recent PRs...
It's just a matter of time before we are back on the OTCQB...
When that QB uplist happens, Grapefruit will receive an immediate capital infusion pursuant to the deal with their institutional investor (Auctus Fund, LLC). It's in the filings... read them!
This capital infusion will be used to commercialize the Hourglass Patchless Patch.
YES - they have an exclusive license to the underlying nanotechnology that makes the topical effective.
Sources tell me that Grapefruit is already discussing pre-orders of the Hourglass.
There will be huge demand for this innovation.
The future of cannabis lies in dosing and delivery.... GPFT has solved the delivery mechanism problem with cannabis.
Watch the video!
Hourglassâ„¢ Patchless Patchâ„¢ (THC + CBD) PATENTED Time Release Topical | Grapefruit USA (OTC: GPFT)
GPFT - huge upside potential here. $$$
I have been loading at these levels. $0.03 will not last long.
Grapefruit is NOT pre-revenue. They are generating revenues and there is a growth story here on their existing product lines... I expect a stellar 2nd Q revenue report based on the recent PRs...
It's just a matter of time before we are back on the OTCQB...
When that QB uplist happens, Grapefruit will receive an immediate capital infusion pursuant to the deal with their institutional investor (Auctus Fund, LLC). It's in the filings... read them!
This capital infusion will be used to commercialize the Hourglass Patchless Patch.
YES - they have an exclusive license to the underlying nanotechnology that makes the topical effective.
Sources tell me that Grapefruit is already discussing pre-orders of the Hourglass.
There will be huge demand for this innovation.
The future of cannabis lies in dosing and delivery.... GPFT has solved the delivery mechanism problem with cannabis.
Watch the video!
Hourglassâ„¢ Patchless Patchâ„¢ (THC + CBD) PATENTED Time Release Topical | Grapefruit USA (OTC: GPFT)
GPFT - huge upside potential here. $$$
I have been loading at these levels. $0.03 will not last long.
Grapefruit is NOT pre-revenue. They are generating revenues and there is a growth story here on their existing product lines... I expect a stellar 2nd Q revenue report based on the recent PRs...
It's just a matter of time before we are back on the OTCQB...
When that QB uplist happens, Grapefruit will receive an immediate capital infusion pursuant to the deal with their institutional investor (Auctus Fund, LLC). It's in the filings... read them!
This capital infusion will be used to commercialize the Hourglass Patchless Patch.
YES - they have an exclusive license to the underlying nanotechnology that makes the topical effective.
Sources tell me that Grapefruit is already discussing pre-orders of the Hourglass.
There will be huge demand for this innovation.
The future of cannabis lies in dosing and delivery.... Grapefruit USA (GPFT) has solved the delivery mechanism problem.
Watch the video!
Hourglassâ„¢ Patchless Patchâ„¢ (THC + CBD) PATENTED Time Release Topical | Grapefruit USA (OTC: GPFT)
TNTY - Chart is setting up nicely.
Compounding Pharma Acquisition & Roll Up - ONE TO WATCH
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
***********************************************
TNTY ONE-PAGE INVESTOR INFO SHEET: http://truenaturepharma.com/wp-content/uploads/2017/02/tnty-investor-info-sheet.20170227.pdf
***********************************************
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY - Chart is setting up nicely.
Compounding Pharma Acquisition & Roll Up - ONE TO WATCH
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
***********************************************
TNTY ONE-PAGE INVESTOR INFO SHEET: http://truenaturepharma.com/wp-content/uploads/2017/02/tnty-investor-info-sheet.20170227.pdf
***********************************************
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY NEWS: True Nature Expands Board, Appoints Senior Pharma Executive
February 28, 2017 09:00 ET
Link to News
TNTY NEWS: True Nature Expands Board, Appoints Senior Pharma Executive
February 28, 2017 09:00 ET
Link to News
TNTY NEWS: True Nature Expands Board, Appoints Senior Pharma Executive
February 28, 2017 09:00 ET
Link to News
Couldn't agree more. TNTY had a strong week!
TNTY - Short Squeeze/Breakout ALERT - Pharma Acquisition & Roll-Up Stock.
Profitable pharmacy under LOI. More acquisions to come.
Stock UP 40% today.
Can go much higher with a little bit of support.
For me, this is a buy and hold. If they can roll up pharmacies and become $30M rev company, then it's a prime buy out target.
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
***************************************
TNTY INVESTOR PRESENTATION
***************************************
Website: http://truenaturepharma.com/
TNTY - Pharma Acquisition Play, Possible BREAKOUT/possible SHORT SQUEEZE.
UP 28.33%
Currently trading $0.385. Up on the ASK is $0.425.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
Returned the favor! Yes... spread the word on TNTY.
It's a long term hold for me, but glad to see the shorts covering.
TNTY - Pharma Acquisition Play, Possible BREAKOUT/possible SHORT SQUEEZE.
UP 28.33%
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
TNTY -- Now up 25%. Setting Up.
Possible Short Squeeze about to happen as well.
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
TNTY - Stock is Setting Up for a BREAKOUT.
Pharma Acquisition & Roll-Up Company.
Up 17.5%. Currently trading $0.3525.
$0.32 x 0.375
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
TNTY - Stock is Setting Up for a BREAKOUT.
Pharma Acquisition & Roll-Up Company.
Up 17.5%. Currently trading $0.3525.
$0.32 x 0.375
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
TNTY - Pharma Acquisition - ONE TO WATCH
I speculate that we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
Please visit the iHub message board for more info: TNTY Message Board
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
MISSION: To unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost-effective, and innovative healthcare products and pharmaceuticals to the world.
VISION: To become globally recognized for our best practices focused on driving quality, efficiency, and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.
TNTY 3 MONTH CHART:
Click HERE for TNTY chart.
TNTY - This may fit your speculative investment criteria - KEEP WATCH -
Pharma Acquisition & Consolidation Company
I speculate that we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
The old management team is OUT - New leadership is getting things accomplished. After reading the recent news and filings, it is apparent that the company has learned from what didn't work, and is making significant progress towards multiple acquisitions.
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
Transfer Agent:
VStock Transfer LLC
MISSION: To unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals to the world.
VISION: To become globally recognized for our best practices focused on driving quality, efficiency, and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.
TNTY CHART:
Click HERE for TNTY chart.
TNTY - Moving UP - KEEP WATCH -
Pharma Acquisition & Consolidation Company
I speculate that we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
The old management team is OUT - New leadership is getting things accomplished. After reading the recent news and filings, it is apparent that the company has learned from what didn't work, and is making significant progress towards multiple acquisitions.
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
Transfer Agent:
VStock Transfer LLC
MISSION: To unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals to the world.
VISION: To become globally recognized for our best practices focused on driving quality, efficiency, and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.
TNTY CHART:
Click HERE for TNTY chart.
TNTY - $0.24 x $0.2898 - KEEP WATCH -
Pharma Acquisition & Consolidation Company
I speculate that we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
The old management team is OUT - New leadership is getting things accomplished. After reading the recent news and filings, it is apparent that the company has learned from what didn't work, and is making significant progress towards multiple acquisitions.
COMPANY DESCRIPTION:
True Nature Holding, Inc. (OTCQB: TNTY) is a development stage company focused on consolidating businesses in the compounding pharmacy industry that serve both the human and veterinary markets. The plan contemplates multiple acquisitions of businesses who have traditionally operated locally, but who have specialty formulations that may have a larger market. To achieve its goals, it intends to acquire a number of pharmacies across the US creating a national platform.
SHARE STRUCTURE:
*Authorized Shares: 500,000,000 a/o Feb 01, 2017
*Outstanding Shares: 15,436,666 a/o Feb 01, 2017
*Float: 4,094,877 a/o Feb 01, 2017
*OTC Markets
***************************************
TNTY INVESTOR PRESENTATION
***************************************
TNTY SEC FILINGS
*************************************************
RECENT ACQUISTION NEWS:
True Nature to Acquire Miami Pharmacy Operation; Sees Expansion from Miami to Southeast Region Within 24 Months
ACCESSWIRE: January 19, 2017
*************************************************
CONTACT INFO:
True Nature Holding, Inc.
1355 Peachtree Street
Suite 1150
Atlanta, GA 30309
Phone: (404) 254-6980
Email: contact@truenaturepharma.com
Website: http://truenaturepharma.com/
Transfer Agent:
VStock Transfer LLC
MISSION: To unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals to the world.
VISION: To become globally recognized for our best practices focused on driving quality, efficiency, and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.
TNTY CHART:
Click HERE for TNTY chart.
Good to see you at TNTY mick.
I will be adding to my position over the coming days to weeks.
TNTY - Their business model is simple but powerful. Through acquisition and consolidation of pharmacy businesses, they can leverage economies of scale, make compounding operations more efficient and centralized, grow retail revenue, and monetize the intellectual property from each pharmacy's drug formulation library -- a.k.a. INTELLECTUAL PROPERTY.
INVESTOR PRESENTATION
Stock is starting to wake up again. I don't think we will see these lows for long.
52 week high $3.48. Float is small. I don't see why they can't get back there now that the new management team cleaned up the company.
Well... you certainly made an excellent call there.
Thank you for the welcome message! Feels great to contribute.
Re: TNTY - I believe we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
The old management team is OUT - New leadership is getting things accomplished. After reading the recent news and filings, it is apparent that the company has learned from what didn't work, and is making significant progress towards an acquisition.
I think it might be a good one to keep on your radar.
Re: TNTY - I believe we will continue to see news and updates consistent with a company focused on execution and making a solid turn around.
The old management team is OUT - New leadership is getting things accomplished. After reading the recent news and filings, it is apparent that the company has learned from what didn't work, and is making significant progress towards an acquisition.
I think it might be a good one to keep on your radar.